The Leukemia Atlas: researchers unveil proteins that signal disease
Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis. To improve that survival rate, researchers at The University of Texas at San Antonio (UTSA) and ...
Apr 17, 2019
0
126